Your session is about to expire
← Back to Search
Oral Administration for Pelvic Floor Dysfunction
Study Summary
This trial is testing if an alternative way to take the drug diazepam can help control discomfort and poor sleep quality caused by levator ani syndrome, while minimizing drowsiness.
- Pelvic Floor Dysfunction
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Who is running the clinical trial?
Frequently Asked Questions
How many participants has this clinical trial recruited so far?
"Affirmative. According to clinicaltrials.gov, this research endeavour is in the process of recruiting individuals for participation. This investigation was initially listed on September 1st 2020 and has been refreshed as recently as August 8th 2022; it aims to enrol 100 people across a single center."
In what instances is Oral Administration the preferred treatment?
"Oral Administration is a method of administering medication to patients, which can be employed for sedation or used as part of treatment plans for athetosis, refractory epilepsy and syndrome."
Is there still room available to join this research project?
"Affirmative. According to information hosted on clinicaltrials.gov, the trial began accepting applications in early January 2020 and is still recruiting as of August 2022. The study requires 100 participants from single site for enrollment."
Have there been prior experiments with Oral Administration?
"Currently, 5 clinical trials are conducting research on Oral Administration. None of these studies have progressed to Phase 3 yet. Although the majority of these live trials are located in Ratchathewi, Bangkok, there is a total 19 different medical sites that partaking in this experiment."
Is it safe to administer treatments orally for patients?
"Oral Administration has already been approved for public use, so it received a safety rating of 3."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger